Insights
Reimagining the future
Deep Tech
Edge Image Processing: Development of a Robust Sensor Platform for Bore-Hole Detection on Autonomous Ground Vehicles in Open-Pit Mines
Healthcare
The long game: how strategic thinking prevents medical device development failure
Deep Tech
Using AI foundation models to unlock the full potential of digital twins
Life Science
UTI Diagnostics: An opportunity to improve antimicrobial stewardship and women’s health
Life Science
Do you trust your software? Why you should seriously consider using Rust in your next diagnostic and medical device
Life Science
Plug and play genomics for next-gen therapies
Life Science
Distributing diagnostics: locations, motivations, metrics
Cell and Gene Therapy
Non-contact cell counting enables in-line, real-time monitoring of manufacturing processes
Cell and Gene Therapy
Treatment of chronic conditions is the new frontier for stem cell-derived therapies: Deep phenotyping and manufacturing scale-up key to opening clinic doors, say experts at TTP’s panel discussion
Life Science
In the Hot Seat: Challenging Conventions in Precision Medicine
Life Science
Personalised mRNA therapies are coming and will challenge established analytical technologies: Should we look to the diagnostics sector for improved Quality Control?
Life Science
Omics: Unlocking a New Era of Quality Control and Treatment Insight for Cell and Gene Therapy
Life Science
A Greener Future of Discovery with More Powerful Drug Screens
Cell and Gene Therapy
With personalised cancer vaccines on the rise, is manufacturing scalable yet?
Life Science
Multi-omics: When Worlds Collide, Opportunities Arise
Life Science
Seven ideas to reduce the environmental impact of point-of-care diagnostics
Life Science
A new era in point-of-care diagnostic testing: possibilities and practicalities
Life Science
Shape Up, Library Prep: Innovating for Efficient, Low Cost and Sustainable Workflows
Life Science
Environmental DNA and RNA: versatile tools with huge untapped commercial potential
Life Science
Diagnostics: areas of growth, change, and wider interest that could transform the industry
Life Science
How is cell and gene therapy innovation adapting to a changing investment landscape? Insights from TTP’s Cell & Gene panel event
Life Science
Are we entering a new era in point-of-care diagnostic testing?
Life Science
How can you prove 99.9% reliability? A challenge in automating and scaling cell therapies
Life Science
Spatial biology: FISH and sequencing reveal gene expression patterns. Where is the industry now, and what will the future bring?
Life Science
Translating spatial biology into tissue diagnostics with inventive technology
Life Science
Next-generation sample preparation: Will better nucleic acid extraction unleash biotechnology, life sciences and diagnostics?
Life Science
As we predicted: Isothermal amplification diagnostics shoot to prominence in point-of-care market
Life Science
Could the “chip shortage” hit your product? Here’s what to do.
Life Science
Multiplex cytokine measurement: Covid and beyond
Life Science
The antimicrobial susceptibility testing conundrum
Life Science
Front-loading monoclonal antibody screening for faster drug discovery
Life Science
What failure rate are we willing to accept in cell therapy manufacture? Insights from medical device development
Life Science
Biomimetics evolution at the micron scale and beyond
Life Science
Special Delivery: can advanced intracellular delivery enable superior cell therapies for solid tumour treatment – and beyond?
Life Science
Only a ‘click’ away: click chemistry transforms life science applications
Life Science
DNA Origami: What can we make of it?
Life Science
Key early-stage microfabrication decisions for life science start-ups and SMEs
Life Science
Spotlight on upconversion nanoparticles: finding the right chemistry to make life science applications “click”
Life Science
Imaging by the numbers: quantitative imaging for digital pathology
Life Science
How to develop microfluidics for commercial products
Life Science
Could technology help contain the next equine flu epidemic?
Life Science
New modes of drug action tackle intractable diseases
Life Science
The future of molecular diagnostics: Will isothermal amplification techniques steal PCR’s crown in the close-to-patient era?
Life Science
Can we imagine a future of personalised medicine based on the analysis of lipids and carbohydrates?
Life Science
Driving Cell Therapy Innovation: Applying Key Lessons from the Evolution and Commercialization of Protein-Based Therapies
There are no insights for your current selection. Please select a different industry.